Synthetic binders developer Aptamer Group has signed a licensing agreement with Alphazyme for the use of an Optimer binder in ...

Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...

A new approach by chemists could help to significantly improve diagnostic tests based on PCR. The enzymes used are triggered by light pulses. DNA polymerases and other enzymes that modify DNA are ...